Revance Therapeutics, Inc. (RVNC)
Feb 6, 2025 = RVNC was delisted (reason: acquired by Crown Laboratories)
3.650
0.00 (0.00%)
Inactive · Last trade price
on Feb 6, 2025
Revance Therapeutics Market Cap
Revance Therapeutics is not actively traded anymore. When Revance Therapeutics last traded, it had a market cap or net worth of $383.05 million.
Market Cap
383.05M
Enterprise Value
682.42M
1-Year Change
-27.66%
Ranking
Category
Stock Price
$3.65
Market Cap Chart
Since February 6, 2014, Revance Therapeutics's market cap has decreased from $453.20M to $383.05M, a decrease of -15.48%. That is a compound annual growth rate of -1.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2025 | 382.90M | 20.07% |
| Dec 31, 2024 | 318.90M | -58.69% |
| Dec 29, 2023 | 771.90M | -49.18% |
| Dec 30, 2022 | 1.52B | 29.62% |
| Dec 31, 2021 | 1.17B | -37.87% |
| Dec 31, 2020 | 1.89B | 157.62% |
| Dec 31, 2019 | 732.10M | -1.68% |
| Dec 31, 2018 | 744.60M | -32.67% |
| Dec 29, 2017 | 1.11B | 87.35% |
| Dec 30, 2016 | 590.30M | -38.42% |
| Dec 31, 2015 | 958.60M | 138.58% |
| Dec 31, 2014 | 401.80M | -11.34% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition